Theralase Technologies Inc. V.TLT

Not long until the AGM

[Oilminerdeluxe]

Anyone here going to the AGM? Just wondering. Sharpen your questions.

[DJDawg]

Some of us are too far away. Would be great if someone active on this board could update the rest of us in a timely fashion about what goes down. We would be grateful :)

[Oilminerdeluxe]

Agree. Hopefully, it will not be a snoozefest

[Jaro1977]

If they take questions at the AGM, what would you be asking?

[CancerSlayer]

  The most important wish for me is to have the ability to better gauge the durability of response.  I would want to know the "absolute number" of patients who have reached the 270, 360 & 450 day assessment marks, & what number or percentage of those patients are CR.  They could report these numbers for optimized patients only (+/- Ph 1b patients) & for the

[ScienceFirst]

Details on patients is material info as it can influence the share price, so it has to be release to all, at the same time.

[Legit62]

Thats right to the point CancerSlayer, i would want to know exact info, this would give us clear cut numbers and we would have to do less analysing, which is all over the place on this board, it changes every day. It would be nice if someone here goes to the AGM. And pass on info

[ScienceFirst]

  Details on patients is material info as it can influence the share price, so it has to be released to all, at the same time. So the AGM cannot be the place, contrary the the beliefs of some here.  You have to know the rules that companies have to follow and that are imposed by regulators. Details on patients is material info as it can influence the share price, so it has to be

[ScienceFirst]

Recently, the company used 4 events to publish an update on the Ph. 2!clinical trial; - the Nov. 29 newsletter - the April 5 clinical update - the April 29 financial (FY2021) - the May 30 financials  (Q1-2022) (3 more patients) The next one would be with the financials around late August, that's a certainty.  Until then, it would have to be via a press release, no matter the

[consultant99]

The AGM will be held after the market is closed and as long as anything presented at the meeting is posted before the market opens where is the problem? I would hope the company would provide context if not new information on how the trial is progressing and future expectations. In fairness I have never attended a TLT annual meeting but I have attended AGMs of other companies.

[StevenBirch]

You are right there is nothing stopping them from updating at the AGM but it would come with an official news release after the market closed I am sure. Either way there is still a lot of info that can be shared, like at the last one after the hated PP and all the negative talk Roger was adamant there would be no reverse split, that was calming to many. And the fact that the most knowledgeable can

[fredgoodwinson]

Well Sherri is allegedly going to give a Clinical Update at the Gordon Metals in Medicine Conference on the morning of the eve of the AGM - not quite sure how that works but would be great if someone could publish a transcript before our meeting.

[ScienceFirst]

Dr. McFarland is not in the know more than us, when it comes to Ph. 2 clinical data, as she's not part of the TLT management.  She's on the same level as us, as strange as it can sound for some here, especially when  considering that she's the creator of our molecule inn2011. 

[fredgoodwinson]

She`ll be ill-equipped to provide the information that is the basis of her lecture then.

[ScienceFirst]

Exact.  She will give the info that is accessed to everybody, as she doesn't have more info anyways.

[ScienceFirst]

Exact.  She will give the info that is accessible to everybody, as she doesn't have more info anyways.

[ScienceFirst]

Dr. McFarland registered to her conference months in advance. TLT's AGM date is usually around the current period. So there's no link between both events.  So nothing strategic.  

[fredgoodwinson]

OK - so really she`ll be telling them the most recent info that she`s been told herself - not necessarily current.

[ScienceFirst]

She works with the data available to the public as she doesn't have more insights than this public, because of the regulatory rules.

[fredgoodwinson]

That`s understood - although some of her past published comments have suggested greater operational insight than mine (for example!).

[Eoganacht]

Dr. McFarland will likely be revealing to the rest of the world the same data we TLT-heads have been going over for months, as we try to squeeze a little extra insight from the bare facts revealed in the news releases. The difference is that Dr. McFarland is in a better position to better understand the significance of some of the factual tidbits that may have gone over our heads.

[Johnandrose22]

TLT Heads....Love it...and your post is spot on, Eoganacht.

[99942Apophis]

Good points Eoganacht, my thought is not unlike many here that as hospitals in both countries clear away the backlog of elective surgery we should see less patient strain/anxiety in our PH2 trial thus moving the CR rates higher. As CancerSlayer once said within this trial we have our own comparative groups in the undertreated and the optimized, will Dr. Sherri McFarland  use this in her

[BlueFranky]

Apoph... Your last line and the image of her carrying the torch on that day... after all she and fellow suffers have been through ... Made my eyes water Godspeed.

[fredgoodwinson]

Yes CS it`s not just a question for the AGM but price sensitive information seminal to any ability to properly value TLT that being in the Company`s possession and not of commercial sensitivity in relation to their intellectual property should absolutely have been released in a clear and unambiguous format already.